HCV Subtype Characterization among Injection Drug Users: Implication for a Crucial Role of Zhenjiang in HCV Transmission in China

被引:36
|
作者
Zhang, Chiyu [1 ]
Wu, Nana [1 ]
Liu, Jun [1 ]
Ge, Qinjuan [2 ]
Huang, Yan [1 ]
Ren, Qian [1 ]
Feng, Qingchuan [1 ,3 ]
He, Guangli [2 ]
机构
[1] Jiangsu Univ, Inst Life Sci, Jiangsu, Peoples R China
[2] Zhenjiang Ctr Dis Control & Prevent, Jiangsu, Peoples R China
[3] Zhengzhou Univ, Coll Basic Med, Dept Cell Biol & Med Genet, Zhengzhou, Herts, Peoples R China
来源
PLOS ONE | 2011年 / 6卷 / 02期
关键词
HEPATITIS-C-VIRUS; GENOTYPE DISTRIBUTION; GENETIC DIVERSITY; HIGH PREVALENCE; HEROIN USERS; HIV-1; EPIDEMIOLOGY; INFECTION; COINFECTION; SPREAD;
D O I
10.1371/journal.pone.0016817
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: HCV transmission is closely associated with drug-trafficking routes in China. However, the transmission route of HCV in Eastern China remains unclear. Here, we investigate the role of Zhenjiang city of Jiangsu province, an important transportation hub linking Shanghai with other regions of China, in HCV transmission. Methodology/Principal Findings: A total of 141 whole blood samples were collected from injection drug users (IDUs) in Zhenjiang and then tested for HCV infection. Of them, 115 HCV positive plasmas were subjected to RNA extraction, RT-PCR amplification, and sequencing. The subtype characterization and the evolutionary origin of HCV strains circulating in Zhenjiang were determined using polygenetic or phylogeographic analyses. Seven HCV subtypes 1b, 2a, 3a, 3b, 6a, 6e and 6n were detected among Zhenjiang IDUs, showing a complex HCV epidemic. The most predominant subtypes were 3a (38%) and 1b (26.8%). Among these subtypes, subtypes 3b, 6n and 6e originated from Southwestern China (i.e., Yunnan and/or Guangxi), subtypes 2a and 6a from Southern China (i.e., Guangdong), subtype 1b from Central (i.e., Henan) and Northwestern (i.e., Xinjiang) China, and subtype 3a from Southwestern (i.e., Yunnan) and Northwestern (i.e., Xinjiang) China. From Zhenjiang, subtypes 1b and 2a were further spread to Eastern (i.e., Shanghai) and Northern (i.e., Beijing) China, respectively. Conclusions/Significance: The mixing of seven HCV subtypes in Zhenjiang from all quarters of China indicates that as an important middle station, Zhenjiang plays a crucial role in HCV transmission, just as it is important in population migration between other regions of China and Eastern China.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] HCV transmission among injection drug users
    Nature Clinical Practice Gastroenterology & Hepatology, 2005, 2 (6): : 252 - 252
  • [2] Complicated HCV subtype expansion among drug users in Guangdong province, China
    Yan, Jin
    Fu, Xiao-Bing
    Zhou, Ping-Ping
    He, Xiang
    Liu, Jun
    Huang, Xu-He
    Yu, Guo-Long
    Yan, Xin-Ge
    Li, Jian-Rong
    Li, Yan
    Lin, Peng
    INFECTION GENETICS AND EVOLUTION, 2019, 73 : 139 - 145
  • [3] Can HCV be prevented among injection drug users?
    Newmeyer, J
    JOURNAL OF PSYCHOACTIVE DRUGS, 2002, 34 (04) : 421 - 425
  • [4] Differences in HCV subtype distribution according to primary drug of choice among injection drug users.
    Krekulova, L
    Rehak, V
    Johnson, M
    Riley, LW
    HEPATOLOGY, 2001, 34 (04) : 564A - 564A
  • [5] Identification of a New HCV Subtype 6xg Among Injection Drug Users in Kachin, Myanmar
    Ye, Mei
    Chen, Xin
    Wang, Yu
    Duo, Lin
    Zhang, Chiyu
    Zheng, Yong-Tang
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [6] The Molecular Epidemiological Study of HCV Subtypes among Intravenous Drug Users and Non-Injection Drug Users in China
    Tao, Jun
    Liang, Jun
    Zhang, Hui
    Pei, Lijian
    Qian, Han-zhu
    Chambers, Matthew C.
    Jiang, Yan
    Xiao, Yao
    PLOS ONE, 2015, 10 (10):
  • [7] HCV GENOTYPE 1 SUBTYPE IDENTIFICATION, A CRUCIAL STEP IN NEW HCV DRUG DEVELOPMENT
    Chevaliez, S.
    Bouvier-Alias, M.
    Brillet, R.
    Pawlotsky, J. -M.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S6 - S6
  • [8] Review of HIV and HCV infection among drug users in China
    Bao, Yan-ping
    Liu, Zhi-min
    Lu, Lin
    CURRENT OPINION IN PSYCHIATRY, 2010, 23 (03) : 187 - 194
  • [9] Molecular Epidemiology of HCV Monoinfection and HIV/HCV Coinfection in Injection Drug Users in Liuzhou, Southern China
    Tan, Yi
    Wei, Qi Hou
    Chen, Liu Jun
    Chan, Pui Chung
    Lai, Wen Sheng
    He, Ming Liang
    Kung, Hsiang Fu
    Lee, Shui Shan
    PLOS ONE, 2008, 3 (10):
  • [10] HIGH BURDEN OF HCV AND HCV/HIV COINFECTION AMONG INJECTION DRUG USERS IN INDIA: NEED FOR INTEGRATION OF HIV AND HCV SERVICES
    Solomon, S. S.
    Mehta, S. H.
    Srikrishnan, A. K.
    Lucas, G. M.
    McFall, A.
    Laeyendecker, O.
    Kumar, M. S.
    Iqbal, S. H.
    Solomon, S.
    Quinn, T. C.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S516 - S516